A comparative study evaluating the efficacy of naltrexone versus acamprosate as anticraving agents in alcohol use disorder
Background: Alcohol use disorders (AUDs) are characterized by excessive alcohol consumption, negatively impacting health, social life, and economic status. Globally, AUD contributes to significant disease burden, causing millions deaths annually. Despite the availability of treatments, relapse rates...
Saved in:
| Main Authors: | Samant Singh, Lakhan Kataria, Mohd Rashid Alam |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2025-01-01
|
| Series: | Industrial Psychiatry Journal |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/ipj.ipj_413_24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Low dose baclofen and standard dose acamprosate had comparable changes in brain glutamate, brain Gamma amino butyric acid (GABA) and craving among patients with alcohol dependence syndrome: A 1H-MRS based open label randomized study
by: Akhil Kesan, et al.
Published: (2025-01-01) -
Review of acamprosate pharmacokinetics and dosing strategies
by: Lauren Steil, PharmD, et al.
Published: (2025-04-01) -
Neuroprotective role of acamprosate and rasagiline in epilepsy: In silico and in vivo study
by: Kumar Sandeep, et al.
Published: (2025-01-01) -
RATIONALE FOR THE SELECTION OF AUXILIARY COMPONENTS FOR THE NALTREXONE HYDROCHLORIDE NASAL SPRAY
by: Y. M. Domnina, et al.
Published: (2019-01-01) -
Lack of response of Chikungunya chronic infection with low-dose naltrexone: a case series
by: J. Carvalho
Published: (2024-04-01)